Prospective commercial buyer
Refoot Functional Orthotics
10units intended
Signed commercial letter of intent.
An expression of commercial intent, not a confirmed order or revenue.For investors
Help bring instability tracking into everyday life.
A working cane prototype. Now developing automatic tracking of losses of balance, including recovery without a fall.
The ask
₪350,000for 12 months
AI refinement, an integrated pilot product and supervised evaluation.
Funding target for the next development stage; not secured capital.Working MVP · AI development underway · Non-medical prototype
Progress you can see
A working MVP.
A team moving forward.
Our local demonstration visualises cane movement in real time, shows cane-use status and demonstrates unusual-movement and suspected-fall alerts.
The working MVP at a demonstration
See the prototype with our team.
Request a demonstration Demonstration capabilities, not validated detection accuracy.Early relationships
Early belief in Supporta.
Community support
TELEM
TELEM is an Israeli nonprofit supporting adults aged 60+. It supports Supporta through a support letter and potential future collaboration.
Potential collaboration, not a completed pilot or purchase.Proposed business model
B2B2C business model.
Supporta
Cane + platform
Distribution partner
The route to everyday use
User + family
Independence + connection
Proposed target pricing
- Product purchase
- ₪1,690per cane · target price
A one-time cane purchase through a distribution partner.
- Continuing service
- ₪39per month · target price
A planned monthly service connecting the cane experience with family awareness.
Proposed pricing and commercial model; not a current purchase offer.
Commercial assumptions and wider market context
The partner route is intended to bring Supporta into existing mobility-product channels. Refoot is a prospective buyer, not a confirmed customer. Who pays the monthly service fee, partner margins and final commercial terms remain to be agreed.
2026 estimate
$286.4BGlobal AgeTech
Silver Economy2024 estimate
$9.7BGlobal fall prevention products
DataHorizzon ResearchIndependent estimates of broad markets, not Supporta revenue or obtainable market size.
What investment enables
From working prototype
to a meaningful pilot.
Proposed evaluation aims, not achieved results
- A pilot-ready cane
- Integrated hardware and software with documented readiness checks.
- A detection-performance report
- Compare counts with independently documented episodes, missed events and false detections.
- Evidence of everyday usefulness
- Test usability and family understanding alongside recorded cane-use time and missing-data gaps.
Future dates are planning targets, subject to funding, validation, and readiness.
September 2026
Working MVP
Current stageSeptember 2026
Tnufa / grant applications
PlannedQ4 2026 – Q1 2027
Pilot-ready product
PlannedQ1 – Q2 2027
Supervised pilot
PlannedQ2 – Q3 2027
Validated V2
Target
Beyond the pilot · production and expansion targets
Q3 – Q4 2027
Production preparation
PlannedQ4 2027 – Q1 2028
First Refoot order
Target2028
Partner sales
Planned2028 – 2029
Scale in Israel
Planned2029 onward
International expansion
Vision
A first Refoot order is a target, not a confirmed order or revenue. International expansion remains a longer-term vision.
Detection accuracy has not yet been validated; “Validated V2” is a future target. Advance fall warning and fall reduction remain separate, longer-term research goals.
Why this team
A team built through practice.
Our founders first worked together on a wearable EMS device, winning second place at Braude College’s Golden Age Hackathon in March 2023. That experience helped shape Supporta, which we developed later as a separate product.
CEO & Co-founder
Bshara Habib
Leads strategy, fundraising and partnerships.
COO & Co-founder
Yareen Hamdan
Leads operations, execution and management.
CTO & Co-founder
Francis Aboud
Leads engineering, architecture and data.
2023 · Second placeGolden Age Hackathon · wearable EMS project
2026 · Third placeOfek Tech Demo Day · Supporta
Meet the teamA private invitation
Ready for a closer look?
Discuss the evidence, assumptions, and next investment milestone.
Request accessPrivate investor roomAccess requiredIllustrative preview · Private review by invitation.